<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Psychol Med</journal-id><journal-id journal-id-type="iso-abbrev">Psychol Med</journal-id><journal-id journal-id-type="publisher-id">PSM</journal-id><journal-title-group><journal-title>Psychological Medicine</journal-title></journal-title-group><issn pub-type="ppub">0033-2917</issn><issn pub-type="epub">1469-8978</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40314172</article-id><article-id pub-id-type="pmc">PMC12094658</article-id>
<article-id pub-id-type="doi">10.1017/S0033291725001163</article-id><article-id pub-id-type="pii">S0033291725001163</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Associations of childhood adversity and substance use disorder polygenic scores with disorder severity and diagnostic criteria</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>SooHoo</surname><given-names>Jackson F.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Davis</surname><given-names>Christal N.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Angela</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Jinwala</surname><given-names>Zeal</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gelernter</surname><given-names>Joel</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Feinn</surname><given-names>Richard</given-names></name><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1018-0450</contrib-id><name><surname>Kranzler</surname><given-names>Henry R.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor1" ref-type="corresp"/></contrib></contrib-group><aff id="aff1">
<label>
1
</label>Center for Studies of Addiction, Department of Psychiatry, <institution>University of Pennsylvania School of Medicine</institution>, <city>Philadelphia</city>, <state>PA</state>, <country>USA</country>
</aff><aff id="aff2">
<label>
2
</label>Mental Illness Research, Education, and Clinical Center, <institution>Crescenz VAMC</institution>, <city>Philadelphia</city>, <state>PA</state>, <country>USA</country>
</aff><aff id="aff3">
<label>
3
</label>Department of Psychiatry, <institution>Yale University School of Medicine</institution>, <city>New Haven</city>, <state>CT</state>, <country>USA</country>
</aff><aff id="aff4">
<label>
4
</label>
<institution>VA Connecticut Healthcare System</institution>, <city>West Haven</city>, <state>CT</state>, <country>USA</country>
</aff><aff id="aff5">
<label>
5
</label>Department of Medical Sciences, Frank H. Netter School of Medicine, <institution>Quinnipiac University</institution>, <city>North Haven</city>, <state>CT</state>, <country>USA</country>
</aff><author-notes><corresp id="cor1">
<bold>Corresponding author:</bold> Henry R. Kranzler; Email: <email>kranzler@pennmedicine.upenn.edu</email>
</corresp><fn id="fn01" fn-type="other"><p>Jackson F. SooHoo and Christal N. Davis contributed equally to this work.</p></fn></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2025"><year>2025</year></pub-date><pub-date pub-type="epub"><day>02</day><month>5</month><year>2025</year></pub-date><volume>55</volume><elocation-id>e132</elocation-id><history><date date-type="received"><day>02</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>06</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>14</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0</uri>), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0033291725001163a.pdf"/><abstract><sec id="sec1"><title>Background</title><p>Genetic and environmental factors, including adverse childhood experiences (ACEs), contribute to substance use disorders (SUDs). However, the interactions between these factors are poorly understood.</p></sec><sec id="sec2"><title>Methods</title><p>We examined associations between SUD polygenic scores (PGSs), ACEs, and the initiation of use and severity of alcohol (AUD), opioid use disorder (OUD), and cannabis use disorder (CanUD) in 10,275 individuals (43.5% female, 47.2% African-like ancestry [AFR], and 52.8% European-like ancestry [EUR]). ACEs and SUD severity were modeled as latent factors. We conducted logistic and linear regressions within ancestry groups to examine the associations of ACEs, PGS, and their interaction with substance use initiation and SUD severity.</p></sec><sec id="sec3"><title>Results</title><p>All three SUD PGS were associated with ACEs in EUR individuals, indicating a gene&#x02013;environment correlation. Among EUR individuals, only the CanUD PGS was associated with initiating use, whereas ACEs were associated with initiating use of all three substances in both ancestry groups. Additionally, a negative gene-by-environment interaction was identified for opioid initiation in EUR individuals. ACEs were associated with all three SUD severity latent factors in EUR individuals and with AUD and CanUD severity in AFR individuals. PGS were associated with AUD severity in both ancestry groups and with CanUD severity in AFR individuals. Gene-by-environment interactions were identified for AUD and CanUD severity among EUR individuals.</p></sec><sec id="sec4"><title>Conclusions</title><p>Findings highlight the roles of ACEs and polygenic risk in substance use initiation and SUD severity. Gene-by-environment interactions implicate ACEs as moderators of genetic susceptibility, reinforcing the importance of considering both genetic and environmental influences on SUD risk.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Childhood adversity</kwd><kwd>polygenic scores</kwd><kwd>substance use disorders</kwd><kwd>diagnostic criteria</kwd><kwd>gene-environment interaction</kwd></kwd-group><funding-group><award-group id="aw001"><funding-source>
<institution-wrap><institution>National Institute on Alcohol Abuse and Alcoholism</institution><institution-id institution-id-type="doi">http://dx.doi.org/10.13039/100000027</institution-id></institution-wrap>
</funding-source><award-id>AA030056</award-id><principal-award-recipient>Henry Kranzler</principal-award-recipient></award-group></funding-group><counts><fig-count count="2"/><table-count count="3"/><ref-count count="54"/><page-count count="8"/></counts></article-meta></front><body><sec sec-type="intro" id="sec5"><title>Introduction</title><p>Substance use disorders (SUDs) are chronic conditions characterized by impaired control over substance use and disrupted functioning. In 2022, SUDs affected more than 48 million U.S. individuals (Center for Behavioral Health Statistics and Quality, <xref rid="r4" ref-type="bibr">2023</xref>), contributing to morbidity and mortality (Ahmad, Cisewsk, Rossen, &#x00026; Sutton, <xref rid="r2" ref-type="bibr">2024</xref>; National Institute on Alcohol Abuse and Alcoholism (NIAAA), <xref rid="r40" ref-type="bibr">2024</xref>). Despite their prevalence and impact, there are gaps in our understanding of SUDs, including how known risk factors, such as genetic liability and adverse childhood experiences (ACEs), may differentially relate to substance use initiation and SUDs.</p><p>Genetic, environmental, and gene-by-environment influences are all associated with the development of SUDs (Deak &#x00026; Johnson, <xref rid="r8" ref-type="bibr">2021</xref>; Milaniak, Watson, &#x00026; Jaffee, <xref rid="r34" ref-type="bibr">2015</xref>). Although influenced by environmental factors (particularly family environment), SUDs are highly polygenic, with heritability estimates of about 50% (Deak &#x00026; Johnson, <xref rid="r8" ref-type="bibr">2021</xref>). Compared to SUDs, twin studies show that substance use initiation is more strongly influenced by environmental factors, with heritability estimates of only about 40% (Agrawal &#x00026; Lynskey, <xref rid="r1" ref-type="bibr">2006</xref>; Kendler, Karkowski, Neale, &#x00026; Prescott, <xref rid="r24" ref-type="bibr">2000</xref>; Koopmans, Slutske, van Baal, &#x00026; Boomsma, <xref rid="r26" ref-type="bibr">1999</xref>; Verweij et al., <xref rid="r51" ref-type="bibr">2010</xref>). In addition, twin and molecular genetic studies suggest a combination of shared and distinct genetic and environmental factors influencing substance use initiation and the development of the disorder. For example, twin studies have found that 62% of the genetic variation in cannabis abuse is shared with initiation, with the remaining proportion being genetic influences unique to abuse (Gillespie, Neale, &#x00026; Kendler, <xref rid="r15" ref-type="bibr">2009</xref>). Similarly, recent genome-wide association studies (GWASs) of substance use have demonstrated that genetic liability for initiation/use and disorder are genetically correlated (Johnson et al., <xref rid="r20" ref-type="bibr">2020</xref>; Quach et al., <xref rid="r44" ref-type="bibr">2020</xref>; Sanchez-Roige, Palmer, &#x00026; Clarke, <xref rid="r46" ref-type="bibr">2020</xref>). However, initiation and disorder also have some distinct genetic correlations, with these associations sometimes being in opposite directions (Pasman et al., <xref rid="r42" ref-type="bibr">2018</xref>).</p><p>Polygenic scores (PGSs) can provide an aggregate estimate of an individual&#x02019;s genetic liability for SUDs, capturing the polygenic nature of substance use initiation and SUDs. Prior research using phenome-wide association studies (PheWAS) showed that substance-related PGS are associated with substance use initiation and SUDs, as well as other related traits (e.g., major depressive disorder criterion count, PTSD criterion count, and health rating; Kember et al., <xref rid="r22" ref-type="bibr">2023</xref>). With the availability of more powerful GWAS, it is critical to further examine these associations and consider the potential role of moderating environmental variables.</p><p>ACEs, which have been associated with risk for SUDs and other psychiatric disorders (Leza, Siria, L&#x000f3;pez-Go&#x000f1;i, &#x00026; Fern&#x000e1;ndez-Montalvo, <xref rid="r30" ref-type="bibr">2021</xref>), may interact with genetic liability to influence both initiation of use and the severity of SUDs. ACEs include physical, sexual, and emotional abuse; neglect; exposure to violence; and familial instability. Although common in the general population (57.6%) (Madigan et al., <xref rid="r31" ref-type="bibr">2025</xref>), ACEs are substantially more common among individuals with SUDs, with estimates that 85.4% to 100% of individuals in SUD treatment have experienced at least one ACE (Leza et al., <xref rid="r30" ref-type="bibr">2021</xref>). A possible mechanism for this association is that individuals may use substances to cope with the trauma of ACEs, which often adversely affect emotion regulation and contribute to the development of maladaptive coping strategies (Cloitre et al., <xref rid="r5" ref-type="bibr">2009</xref>). Consistent with this, a previous study found that individuals who experienced more ACEs were more likely to develop mood and anxiety disorders than those who had not, and these disorders in turn contributed to increased risk of developing SUDs (Kranzler et al., <xref rid="r27" ref-type="bibr">2024</xref>). Prior studies have not, however, examined the interaction between PGS and ACEs in relation to substance use initiation and SUD severity, leaving gaps in our understanding of how these factors jointly shape risk across the continuum from initiation to disorder.</p><p>The current study builds upon previous work that examined the association of ACEs and genetic risk with SUDs (Kranzler et al., <xref rid="r27" ref-type="bibr">2024</xref>; Leza et al., <xref rid="r30" ref-type="bibr">2021</xref>; Meadows et al., <xref rid="r32" ref-type="bibr">2023</xref>; Meyers et al., <xref rid="r33" ref-type="bibr">2015</xref>) by examining: (1) gene&#x02013;environment correlations (rGE) between PGS and ACEs, (2) associations of ACEs and PGS with substance use initiation and latent AUD, OUD, and cannabis use disorders (CanUDs) severity, and (3) gene-by-environment (i.e., PGS &#x000d7; ACEs) interactions on substance use initiation and SUD severity. We expected ACEs to demonstrate more consistent associations with both substance use initiation and SUD severity than PGS. By examining these associations, this study offers a more comprehensive understanding of the interplay among genetic liability, childhood adversity, substance use initiation, and SUDs.</p></sec><sec sec-type="methods" id="sec6"><title>Methods</title><sec sec-type="other" id="sec7"><title>Participants</title><p>Participants were 10,275 individuals from the Yale-Penn sample, a small nuclear family and case&#x02013;control sample ascertained for studies of the genetics of SUDs. Participants were recruited at Yale University, UConn Health, the University of Pennsylvania, the Medical University of South Carolina, and McLean Hospital. Recruitment was from addiction treatment centers, psychiatric services, and through advertisements (Gelernter et al., <xref rid="r13" ref-type="bibr">2014</xref>). Participants gave written informed consent, and study procedures were approved by institutional review boards at all five sites.</p><p>The sample comprised nearly equal numbers of self-identified Black/African American (N&#x000a0;=&#x000a0;4,311) and White (N&#x000a0;=&#x000a0;4,652) individuals, and smaller numbers of individuals of Hispanic/Latino ethnicity (N&#x000a0;=&#x000a0;656) and other race/ethnic groups (N&#x000a0;=&#x000a0;656). Based on genetic principal component (PC) analysis, 4,851 individuals were estimated to be of African-like ancestry and 5,424 individuals of European-like ancestry (<xref rid="tab1" ref-type="table">Table 1</xref>).<table-wrap position="float" id="tab1"><label>Table 1.</label><caption><p>Sample characteristics (N&#x000a0;=&#x000a0;10,275)</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="bottom" rowspan="1" colspan="1">Prevalence (N) or Mean&#x000a0;&#x000b1;&#x000a0;SD</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Sex</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Male</td><td align="center" valign="top" rowspan="1" colspan="1">56.20% (n&#x000a0;=&#x000a0;5,775)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Female</td><td align="center" valign="top" rowspan="1" colspan="1">43.80% (n&#x000a0;=&#x000a0;4,500)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Age</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">40.59&#x000a0;&#x000b1;&#x000a0;11.72</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Genetic ancestry</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;European-like</td><td align="center" valign="top" rowspan="1" colspan="1">52.79% (n&#x000a0;=&#x000a0;5,424)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;African-like</td><td align="center" valign="top" rowspan="1" colspan="1">47.21% (n&#x000a0;=&#x000a0;4,851)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Self-reported race</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;White</td><td align="center" valign="top" rowspan="1" colspan="1">48.96% (n&#x000a0;=&#x000a0;5,030)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Black/African American</td><td align="center" valign="top" rowspan="1" colspan="1">44.64% (n&#x000a0;=&#x000a0;4,587)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Other</td><td align="center" valign="top" rowspan="1" colspan="1">6.40% (n&#x000a0;=&#x000a0;658)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">&#x000a0;&#x000a0;&#x000a0;Married</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">56.89% (n&#x000a0;=&#x000a0;5,846)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">&#x000a0;&#x000a0;&#x000a0;Education (yr)</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">12.78&#x000a0;&#x000b1;&#x000a0;3.04</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">&#x000a0;&#x000a0;&#x000a0;Employed</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1">57.50% (n&#x000a0;=&#x000a0;5,908)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Substance dependence</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Alcohol</td><td align="center" valign="top" rowspan="1" colspan="1">65.64% (n&#x000a0;=&#x000a0;6,744)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Cannabis</td><td align="center" valign="top" rowspan="1" colspan="1">42.94% (n&#x000a0;=&#x000a0;4,412)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Opioids</td><td align="center" valign="top" rowspan="1" colspan="1">32.65% (n&#x000a0;=&#x000a0;3,355)</td></tr></tbody></table><graphic xlink:href="S0033291725001163_tab1" position="float"/></alternatives><table-wrap-foot><p>
<italic toggle="yes">Note:</italic> SD, standard deviation.</p></table-wrap-foot></table-wrap>
</p></sec><sec sec-type="other" id="sec8"><title>Measures</title><p>Participants completed the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA) (Pierucci-Lagha et al., <xref rid="r43" ref-type="bibr">2007</xref>), an interview that assesses lifetime DSM-IV and DSM-5 SUD and psychiatric disorder diagnostic criteria, including for AUD, OUD, and CanUD. Prior to assessing SUD diagnostic criteria, individuals were asked if they had ever used the substance. Those who reported never having used a substance were excluded from SUD analyses for that substance, resulting in a sample of cases and exposed controls for the SUD severity models. As a sensitivity analysis, we used an alternative coding to include both exposed and unexposed controls (see <uri xlink:href="http://doi.org/10.1017/S0033291725001163">Supplementary&#x000a0;Materials</uri>).</p><p>The SSADDA also assesses demographics (e.g., age, sex, relationship/marital status, education, and annual income) and environmental characteristics, including ACEs. Ten variables were used to assess childhood adversity: two reflecting an unstable home life, three measuring traumatic experiences (physical or sexual abuse or witnessing/experiencing a violent crime), two measuring substance use within the household, and three measuring protective factors. These ten variables were used to derive a latent factor representing ACEs (AFR: CFA&#x000a0;=&#x000a0;.997, RMSEA&#x000a0;=&#x000a0;.008, SRMR&#x000a0;=&#x000a0;.057; EUR: CFA&#x000a0;=&#x000a0;.954, RMSEA&#x000a0;=&#x000a0;.030, SRMR&#x000a0;=&#x000a0;.059), with item loadings that ranged from 0.128 to 0.775 (Supplementary <uri xlink:href="http://doi.org/10.1017/S0033291725001163">Table&#x000a0;1</uri>). Although some item loadings were modest, all were significant, and the factor structure was supported by the overall model fit. This 10-item factor has also previously been used within the Yale-Penn sample to explore the role of ACEs in SUD-related outcomes, providing a foundation for its use in the current study (Kranzler et al., <xref rid="r27" ref-type="bibr">2024</xref>).</p><p>In addition to completing the SSADDA, participants provided blood or saliva samples for DNA extraction and genotyping (Gelernter et al., <xref rid="r13" ref-type="bibr">2014</xref>). Genotyping was conducted using the Illumina HumanCoreExome array, Illumina HumanOmni1-Quad microarray, or the Illumina Multi-Ethnic Global array (Illumina, Inc.). We used the Michigan Imputation Server to impute the genetic data with the 1000 Genomes Project Phase 3 as the reference panel (Das et al., <xref rid="r7" ref-type="bibr">2016</xref>). Genetic ancestry was inferred by calculating PCs using single-nucleotide polymorphisms (SNPs) common to both Yale-Penn and the 1000 Genomes Phase 3 reference panel in PLINK 1.9. Individuals were assigned to the closest population group based on distances from 10 PCs (Kember et al., <xref rid="r22" ref-type="bibr">2023</xref>).</p><p>Prior to generating PGS, we obtained summary statistics from GWAS for AUD (N<sub>AFR</sub>&#x000a0;=&#x000a0;121,710, N<sub>EUR</sub>&#x000a0;=&#x000a0;751,607; Zhou et al., <xref rid="r53" ref-type="bibr">2023</xref>), OUD (N<sub>AFR</sub>&#x000a0;=&#x000a0;88,498, N<sub>EUR</sub>&#x000a0;=&#x000a0;302,585; Kember et al., <xref rid="r23" ref-type="bibr">2022</xref>), and CanUD (N<sub>AFR</sub>&#x000a0;=&#x000a0;122,271, N<sub>EUR</sub>&#x000a0;=&#x000a0;884,244; Levey et al., <xref rid="r29" ref-type="bibr">2023</xref>) (Supplementary <uri xlink:href="http://doi.org/10.1017/S0033291725001163">Table&#x000a0;2</uri>). In GWAS that included the Yale-Penn sample, we used summary statistics that excluded that sample to ensure the target sample&#x02019;s independence. For each GWAS, we used ancestry-specific summary statistics and an ancestry-matched linkage disequilibrium (LD) reference panel to calculate PGS. Using PRS-CS software, which uses a Bayesian approach that leverages continuous shrinkage priors to adjust SNP effect sizes while preserving informative signals and accounting for LD structure (Ge et al., <xref rid="r54" ref-type="bibr">2019</xref>), we calculated PGS in the Yale-Penn sample. We applied the software&#x02019;s &#x0201c;auto&#x0201d; option to estimate shrinkage parameters, with the random seed set to one.</p></sec><sec sec-type="other" id="sec9"><title>Data analysis</title><p>We generated latent variables reflecting ACEs and AUD, OUD, and CanUD severity using confirmatory factor analysis and the weighted least square mean and variance-adjusted estimator in Mplus v8.11 (Muth&#x000e9;n &#x00026; Muth&#x000e9;n, <xref rid="r38" ref-type="bibr">1998&#x02013;2017</xref>). To validate the SUD PGS, we first examined their associations with SUD diagnoses in the Yale-Penn sample using within-ancestry logistic regression models that included age, sex, and the first 10 genetic PCs as covariates. In addition, we assessed the presence of gene&#x02013;environment correlations (<italic toggle="yes">rGE</italic>) by calculating Pearson correlations between each PGS and the ACEs factor.</p><p>Next, we examined the association between the PGS, ACEs factor, and initiation of use of alcohol, opioids, and cannabis using logistic regression models. We then conducted linear regression models to examine the associations of the PGS and ACEs factor with AUD, OUD, and CanUD severity. Gene-by-environment interactions between PGS and ACEs were estimated in the same models as the main effects for both initiation and SUD severity. To reduce the potential for confounding, all regression models controlled for age, sex, PGS&#x000d7;age, PGS&#x000d7;sex, ACEs&#x000d7;age, ACEs&#x000d7;sex, and the first ten within-ancestry genetic PCs. Significant gene-by-environment interactions were explored using Johnson&#x02013;Neyman plots to identify the regions of significance, or specifically the range of PGS at which the association between ACEs and the outcome was statistically significant. To examine the impact of limiting SUD severity models to exposed individuals, we conducted sensitivity analyses in which we also included unexposed (never users) individuals.</p></sec></sec><sec sec-type="results" id="sec10"><title>Results</title><sec sec-type="other" id="sec11"><title>PGS validation and gene&#x02013;environment correlations</title><p>The population-specific AUD and CanUD PGS were associated with their respective DSM-5 SUD diagnoses in EUR individuals (AUD: b&#x000a0;=&#x000a0;0.261, SE&#x000a0;=&#x000a0;0.058, p&#x000a0;&#x0003c;&#x000a0;0.001; CanUD: b&#x000a0;=&#x000a0;0.107, SE&#x000a0;=&#x000a0;0.049, p&#x000a0;=&#x000a0;0.029). The AUD PGS was associated with a DSM-5 AUD diagnosis in AFR individuals (b&#x000a0;=&#x000a0;0.141, SE&#x000a0;=&#x000a0;0.066, p&#x000a0;=&#x000a0;0.032). PGS were higher among individuals with SUDs than those without SUD diagnoses in both the EUR (AUD: M<sub>cases</sub>&#x000a0;=&#x000a0;0.137, M<sub>controls</sub>&#x000a0;=&#x000a0;&#x02212;0.193; OUD: M<sub>cases</sub>&#x000a0;=&#x000a0;0.076, M<sub>controls</sub>&#x000a0;=&#x000a0;&#x02212;0.095; CanUD: M<sub>cases</sub>&#x000a0;=&#x000a0;0.156, M<sub>controls</sub>&#x000a0;=&#x000a0;0.004) and AFR groups (AUD: M<sub>cases</sub>&#x000a0;=&#x000a0;0.039, M<sub>controls</sub>&#x000a0;=&#x000a0;&#x02212;0.101; OUD: M<sub>cases</sub>&#x000a0;=&#x000a0;0.101, M<sub>controls</sub>&#x000a0;=&#x000a0;&#x02212;0.024; CanUD: M<sub>cases</sub>&#x000a0;=&#x000a0;0.024, M<sub>controls</sub>&#x000a0;=&#x000a0;0.013).</p><p>In EUR and AFR individuals, there were positive covariances between the CanUD severity factor and the AUD and OUD severity factors (<italic toggle="yes">b</italic>&#x000a0;=&#x000a0;0.093&#x02013;0.359; <xref rid="tab2" ref-type="table">Table 2</xref>). In AFR, but not EUR, individuals, the AUD severity factor covaried with the OUD severity factor <italic toggle="yes">(b&#x000a0;=</italic>&#x000a0;0.068, SE&#x000a0;=&#x000a0;0.032, p&#x000a0;=&#x000a0;0.033). In EUR individuals, ACEs factor scores were correlated with genetic liability for AUD (<italic toggle="yes">rGE</italic>&#x000a0;=&#x000a0;0.120, 95% CI&#x000a0;=&#x000a0;0.092&#x02013;0.147, p&#x000a0;&#x0003c;&#x000a0;0.001), OUD (<italic toggle="yes">rGE</italic>&#x000a0;=&#x000a0;0.164, 95% CI&#x000a0;=&#x000a0;1.37&#x02013;1.90, p&#x000a0;&#x0003c;&#x000a0;0.001), and CanUD (<italic toggle="yes">rGE</italic>&#x000a0;=&#x000a0;0.192, 95% CI&#x000a0;=&#x000a0;0.166&#x02013;0.219, p&#x000a0;&#x0003c;&#x000a0;0.001). In AFR individuals, ACEs were correlated with OUD (<italic toggle="yes">rGE</italic>&#x000a0;=&#x000a0;0.032, 95% CI&#x000a0;=&#x000a0;0.002&#x02013;0.061, p&#x000a0;=&#x000a0;0.036), but neither AUD (<italic toggle="yes">rGE</italic>&#x000a0;=&#x000a0;0.013, 95% CI&#x000a0;=&#x000a0;&#x02212;0.017-0.042, p&#x000a0;=&#x000a0;0.405) nor CanUD (<italic toggle="yes">rGE</italic>&#x000a0;=&#x000a0;0.010, 95% CI&#x000a0;=&#x000a0;&#x02212;0.020-0.039, p&#x000a0;=&#x000a0;0.517).<table-wrap position="float" id="tab2"><label>Table 2.</label><caption><p>Results of logistic regression models for lifetime substance use initiation</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1" valign="bottom"/><th align="center" colspan="3" valign="bottom" rowspan="1">African-like</th><th align="center" colspan="3" valign="bottom" rowspan="1">European-like</th></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Model</th><th align="center" valign="bottom" rowspan="1" colspan="1">Estimate</th><th align="center" valign="bottom" rowspan="1" colspan="1">SE</th><th align="center" valign="bottom" rowspan="1" colspan="1">P-value</th><th align="center" valign="bottom" rowspan="1" colspan="1">Estimate</th><th align="center" valign="bottom" rowspan="1" colspan="1">SE</th><th align="center" valign="bottom" rowspan="1" colspan="1">P-Value</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Alcohol use</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">AUD PGS</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.21</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.15</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.15</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.10</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.14</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">ACEs</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.92</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.21</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c;.001</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.84</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.17</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">ACEs &#x000d7; AUD PGS</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x02212;0.09</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.20</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.66</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x02212;0.02</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.16</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.88</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Cannabis use</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">CanUD PGS</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.32</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.05</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c;.001</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.04</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.05</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.39</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">ACEs</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.59</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.06</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c;.001</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.73</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.06</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">ACEs &#x000d7; CanUD PGS</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x02212;0.05</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.06</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.36</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.02</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.06</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.69</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">Opioid use</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">OUD PGS</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.24</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.13</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.07</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.07</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.04</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">ACEs</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.58</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.04</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c;.001</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.33</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.03</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">ACEs &#x000d7; OUD PGS</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x02212;0.11</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.03</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x0003c;.001</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x02212;0.03</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.03</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.29</td></tr></tbody></table><graphic xlink:href="S0033291725001163_tab2" position="float"/></alternatives><table-wrap-foot><p>
<italic toggle="yes">Note:</italic> Models adjusted for first 10 genetic ancestry principal components, sex, age, and the interactions of sex and age with ACEs and PGS. SE, standard error; AUD, alcohol use disorder; PGS, polygenic score; ACEs, adverse childhood experiences factor; CanUD, cannabis use disorder; OUD, opioid use disorder.</p></table-wrap-foot></table-wrap>
</p></sec><sec sec-type="other" id="sec12"><title>Multivariate regression models</title><p>For the models examining associations with substance use initiation, only the CanUD PGS (but not other SUD PGS) was associated with initiating use in EUR individuals (b&#x000a0;=&#x000a0;0.315, SE&#x000a0;=&#x000a0;0.054, p&#x000a0;&#x0003c;&#x000a0;0.001). In contrast, there were positive associations between ACEs and the initiation of all three substances across both ancestries (<xref rid="tab2" ref-type="table">Table 2</xref>). In addition, there was a negative interaction between ACEs and PGS on opioid initiation in EUR individuals (<xref rid="fig1" ref-type="fig">Figure 1</xref>). The association of ACEs with opioid initiation decreased as PGS increased and became nonsignificant for PGS <inline-formula>
<inline-graphic xlink:href="S0033291725001163_inline90001.jpg"/>
</inline-formula>0.96 standard deviations above the mean.<fig position="float" id="fig1"><label>Figure 1.</label><caption><p>Johnson&#x02013;Neyman plot of the significant gene-by-environment interaction on opioid use initiation. Note: ACEs, &#x02018;adverse childhood experiences&#x02019;; OUD, &#x02018;opioid use disorder&#x02019;; PGS, &#x02018;polygenic score&#x02019;.</p></caption><graphic xlink:href="S0033291725001163_fig1" position="float"/></fig>
</p><p>The AUD PGS was not associated with AUD severity in either AFR or EUR individuals. There were positive associations between ACEs and AUD severity in EUR (b&#x000a0;=&#x000a0;0.179, SE&#x000a0;=&#x000a0;0.052, p&#x000a0;=&#x000a0;0.001) and AFR (b&#x000a0;=&#x000a0;0.316, SE&#x000a0;=&#x000a0;0.058, p&#x000a0;&#x0003c;&#x000a0;0.001) individuals (<xref rid="tab3" ref-type="table">Table 3</xref>). There was a negative gene-by-environment interaction (b&#x000a0;= &#x02212;0.049, SE&#x000a0;=&#x000a0;0.015, p&#x000a0;=&#x000a0;0.001) in EUR, but not AFR, individuals. A Johnson&#x02013;Neyman plot of the interaction indicated that the association between ACEs and AUD severity in EUR individuals weakened as AUD PGS increased, becoming nonsignificant among those with PGS that were <inline-formula>
<inline-graphic xlink:href="S0033291725001163_inline90002.jpg"/>
</inline-formula>one standard deviation above the mean (<xref rid="fig2" ref-type="fig">Figure 2a</xref>).<table-wrap position="float" id="tab3"><label>Table 3.</label><caption><p>Results of linear regression models for substance use disorder severity</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1" valign="bottom"/><th align="center" colspan="3" valign="bottom" rowspan="1">African-like</th><th align="center" colspan="3" valign="bottom" rowspan="1">European-like</th></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Factor</th><th align="center" valign="bottom" rowspan="1" colspan="1">&#x003b2;</th><th align="center" valign="bottom" rowspan="1" colspan="1">SE</th><th align="center" valign="bottom" rowspan="1" colspan="1">P-value*</th><th align="center" valign="bottom" rowspan="1" colspan="1">&#x003b2;</th><th align="center" valign="bottom" rowspan="1" colspan="1">SE</th><th align="center" valign="bottom" rowspan="1" colspan="1">P-value*</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Alcohol</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AUD PGS</td><td align="center" valign="top" rowspan="1" colspan="1">.030</td><td align="center" valign="top" rowspan="1" colspan="1">.064</td><td align="center" valign="top" rowspan="1" colspan="1">.639 (.767)</td><td align="center" valign="top" rowspan="1" colspan="1">.-.012</td><td align="center" valign="top" rowspan="1" colspan="1">.039</td><td align="center" valign="top" rowspan="1" colspan="1">.748 (.748)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ACEs</td><td align="center" valign="top" rowspan="1" colspan="1">.316</td><td align="center" valign="top" rowspan="1" colspan="1">.058</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;.001 (&#x0003c;.001)</td><td align="center" valign="top" rowspan="1" colspan="1">.179</td><td align="center" valign="top" rowspan="1" colspan="1">.052</td><td align="center" valign="top" rowspan="1" colspan="1">.001 (.001)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ACEs &#x000d7; AUD PGS</td><td align="center" valign="top" rowspan="1" colspan="1">.003</td><td align="center" valign="top" rowspan="1" colspan="1">.015</td><td align="center" valign="top" rowspan="1" colspan="1">.830 (.830)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;.049</td><td align="center" valign="top" rowspan="1" colspan="1">.015</td><td align="center" valign="top" rowspan="1" colspan="1">.001 (.002)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Cannabis</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CanUD PGS</td><td align="center" valign="top" rowspan="1" colspan="1">.039</td><td align="center" valign="top" rowspan="1" colspan="1">.076</td><td align="center" valign="top" rowspan="1" colspan="1">.608 (.767)</td><td align="center" valign="top" rowspan="1" colspan="1">.030</td><td align="center" valign="top" rowspan="1" colspan="1">.052</td><td align="center" valign="top" rowspan="1" colspan="1">.568 (.682)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ACEs</td><td align="center" valign="top" rowspan="1" colspan="1">.239</td><td align="center" valign="top" rowspan="1" colspan="1">.072</td><td align="center" valign="top" rowspan="1" colspan="1">.001 (.003)</td><td align="center" valign="top" rowspan="1" colspan="1">.403</td><td align="center" valign="top" rowspan="1" colspan="1">.063</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;.001 (&#x0003c;.001)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ACEs &#x000d7; CanUD PGS</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;.019</td><td align="center" valign="top" rowspan="1" colspan="1">.017</td><td align="center" valign="top" rowspan="1" colspan="1">.260 (.520)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;.040</td><td align="center" valign="top" rowspan="1" colspan="1">.017</td><td align="center" valign="top" rowspan="1" colspan="1">.020 (.040)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Opioid</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">OUD PGS</td><td align="center" valign="top" rowspan="1" colspan="1">.087</td><td align="center" valign="top" rowspan="1" colspan="1">.148</td><td align="center" valign="top" rowspan="1" colspan="1">.554 (.767)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;.125</td><td align="center" valign="top" rowspan="1" colspan="1">.097</td><td align="center" valign="top" rowspan="1" colspan="1">.197 (.296)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ACEs</td><td align="center" valign="top" rowspan="1" colspan="1">.097</td><td align="center" valign="top" rowspan="1" colspan="1">.149</td><td align="center" valign="top" rowspan="1" colspan="1">.518 (.767)</td><td align="center" valign="top" rowspan="1" colspan="1">.049</td><td align="center" valign="top" rowspan="1" colspan="1">.077</td><td align="center" valign="top" rowspan="1" colspan="1">.523 (.682)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ACEs &#x000d7; OUD PGS</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;.007</td><td align="center" valign="top" rowspan="1" colspan="1">.028</td><td align="center" valign="top" rowspan="1" colspan="1">.793 (.830)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;.008</td><td align="center" valign="top" rowspan="1" colspan="1">.020</td><td align="center" valign="top" rowspan="1" colspan="1">.665 (.829)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Factor covariances</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol &#x00026; cannabis</td><td align="center" valign="top" rowspan="1" colspan="1">.359</td><td align="center" valign="top" rowspan="1" colspan="1">.017</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;.001 (&#x0003c;.001)</td><td align="center" valign="top" rowspan="1" colspan="1">.215</td><td align="center" valign="top" rowspan="1" colspan="1">.013</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;.001 (&#x0003c;.001)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Opioids &#x00026; cannabis</td><td align="center" valign="top" rowspan="1" colspan="1">.144</td><td align="center" valign="top" rowspan="1" colspan="1">.033</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;.001 (&#x0003c;.001)</td><td align="center" valign="top" rowspan="1" colspan="1">.093</td><td align="center" valign="top" rowspan="1" colspan="1">.015</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;.001 (&#x0003c;.001)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol &#x00026; opioids</td><td align="center" valign="top" rowspan="1" colspan="1">.068</td><td align="center" valign="top" rowspan="1" colspan="1">.032</td><td align="center" valign="top" rowspan="1" colspan="1">.033 (.079)</td><td align="center" valign="top" rowspan="1" colspan="1">.022</td><td align="center" valign="top" rowspan="1" colspan="1">.015</td><td align="center" valign="top" rowspan="1" colspan="1">.136 (.233)</td></tr></tbody></table><graphic xlink:href="S0033291725001163_tab3" position="float"/></alternatives><table-wrap-foot><p>
<italic toggle="yes">Note:</italic> Models adjusted for first 10 genetic ancestry principal components, sex, age, and the interactions of sex and age with ACEs and PGS. AUD, alcohol use disorder; ACEs, adverse childhood experiences; PGS, polygenic scores; CanUD, cannabis use disorder; OUD, opioid use disorder; &#x003b2;, standardized coefficient; SE, standard error. *The FDR adjusted p-value is shown in parentheses.</p></table-wrap-foot></table-wrap>
<fig position="float" id="fig2"><label>Figure 2.</label><caption><p>Johnson&#x02013;Neyman plots of significant gene-by-environment interactions on substance use disorder severity. (a) results for alcohol use disorder severity, (b) results for cannabis use disorder severity. Note: PGS, &#x02018;polygenic score&#x02019;; ACE, &#x02018;adverse childhood events factor&#x02019;.</p></caption><graphic xlink:href="S0033291725001163_fig2" position="float"/></fig>
</p><p>Among EUR individuals, there were no associations between either the OUD PGS or the ACEs factor with latent OUD severity. There were no gene-by-environment interactions with OUD severity in either ancestry group. Among EUR individuals, there was no association of PGS and CanUD severity. However, in EUR participants, the ACEs factor score was positively associated with CanUD severity (b&#x000a0;=&#x000a0;0.403, SE&#x000a0;=&#x000a0;0.063, p&#x000a0;&#x0003c;&#x000a0;0.001), and there was a negative gene-by-environment interaction (b&#x000a0;=&#x000a0;&#x02212;0.040, SE&#x000a0;=&#x000a0;0.015, p&#x000a0;=&#x000a0;0.020). A Johnson&#x02013;Neyman plot of the interaction showed that the association between ACEs and CanUD severity weakened as CanUD PGS increased and became nonsignificant among those with the highest PGS (Z<inline-formula>
<inline-graphic xlink:href="S0033291725001163_inline90003.jpg"/>
</inline-formula>3.75; <xref rid="fig2" ref-type="fig">Figure 2b</xref>). Among AFR individuals, there was an association of the ACEs factor (b&#x000a0;=&#x000a0;0.239, SE&#x000a0;=&#x000a0;0.072, p&#x000a0;=&#x000a0;0.001) with CanUD severity.</p></sec><sec sec-type="other" id="sec13"><title>Sensitivity analyses</title><p>Including unexposed individuals in the SUD severity models yielded stronger associations of PGS and ACEs with SUD severity than the main analyses (Supplementary <uri xlink:href="http://doi.org/10.1017/S0033291725001163">Tables&#x000a0;4&#x02013;10</uri>). In summary, in both AFR and EUR individuals, the AUD and CanUD PGS were associated with AUD and CanUD severity, respectively. ACEs were associated with all three SUD severity factors in both ancestry groups. In EUR individuals, there were also negative interactions between ACEs and PGS for all three SUD severity factors.</p></sec></sec><sec sec-type="discussion" id="sec14"><title>Discussion</title><p>Examining PGS and ACEs in a large, diverse sample, we found <italic toggle="yes">rGE</italic> between ACEs and SUDs, as well as gene-by-environment interactions between ACEs and SUD PGS on substance use initiation and SUD severity. One possibility for the observed <italic toggle="yes">rGE</italic> is that people who inherit genetic variants associated with SUD risk may be more likely to be exposed to adverse childhood environments (Jaffee &#x00026; Price, <xref rid="r19" ref-type="bibr">2007</xref>) &#x02013; i.e., passive r<italic toggle="yes">GE.</italic> In addition to passing down the contributory genetic variants, parents&#x02019; substance use can adversely shape family life and processes, which in turn influence children&#x02019;s experiences and future substance use (Leonard &#x00026; Eiden, <xref rid="r28" ref-type="bibr">2007</xref>). Negative circumstances, including ACEs and substance use, often cluster together within families, likely resulting from a combination of genetics and within-family environmental influences (Holt, Buckley, &#x00026; Whelan, <xref rid="r18" ref-type="bibr">2008</xref>; Schwartz, Wright, &#x00026; Valgardson, <xref rid="r47" ref-type="bibr">2019</xref>). Importantly, the presence of r<italic toggle="yes">GE</italic> suggests that ACEs are not fully independent of SUD genetic liability.</p><p>Examining substance use initiation, we found that ACEs were associated with having ever used all three substances across both ancestries. In sensitivity analyses, ACEs were more strongly and consistently associated with SUD severity when we included individuals unexposed to substance use in the models, with the enhanced association likely driven by the robust link of ACEs with substance use initiation. PGS and ACEs interacted in association with opioid use initiation, such that the association of ACEs with initiation was reduced as PGS increased. This suggests that the impact of early life adversity on substance use initiation diminishes among those with higher genetic liability for SUDs.</p><p>ACEs were also associated with latent SUD severity, supporting previous research showing that ACEs are implicated in both the initiation of substance use and the severity of SUDs (Deol et al., <xref rid="r9" ref-type="bibr">2023</xref>; Dube et al., <xref rid="r10" ref-type="bibr">2006</xref>; Hines et al., <xref rid="r17" ref-type="bibr">2023</xref>; Meadows et al., <xref rid="r32" ref-type="bibr">2023</xref>). The strength of the associations varied by substance and ancestry group. ACEs were associated with AUD and CanUD severity in both ancestries, suggesting a more robust link to alcohol and cannabis than OUD. ACEs may increase risk for substance use by influencing emotional dysregulation, which contributes broadly to internalizing/externalizing symptoms and disorders (Evans, Goff, Upchurch, &#x00026; Grella, <xref rid="r11" ref-type="bibr">2020</xref>; Garland, Reese, Bedford, &#x00026; Baker, <xref rid="r12" ref-type="bibr">2019</xref>; Gerhardt et al., <xref rid="r14" ref-type="bibr">2023</xref>; Khoury, Tang, Bradley, Cubells, &#x00026; Ressler, <xref rid="r25" ref-type="bibr">2010</xref>; M&#x000fc;ller et al., <xref rid="r37" ref-type="bibr">2015</xref>; Rambau et al., <xref rid="r45" ref-type="bibr">2018</xref>; Sreenivasulu, Prathyusha, Ezhumalai, Narayanan, &#x00026; Murthy, <xref rid="r48" ref-type="bibr">2024</xref>; Tang, Ports, Zhang, &#x00026; Lin, <xref rid="r49" ref-type="bibr">2020</xref>; Tasmim, Le Foll, &#x00026; Hassan, <xref rid="r50" ref-type="bibr">2022</xref>). Overall, ACEs were more consistently and strongly associated with SUDs than the respective PGS, consistent with prior observations in this sample (Na, Deak, Kranzler, Pietrzak, &#x00026; Gelernter, <xref rid="r39" ref-type="bibr">2024</xref>).</p><p>We also found gene-by-environment (i.e., PGS by ACEs) interactions, the directionality of which was consistently negative, such that the impact of ACEs on AUD and CanUD severity was significant except among EUR individuals with higher than average SUD PGS. These findings are consistent with previous analyses in the Yale-Penn sample, including a study in which genetic liability for multiple SUDs similarly moderated the relationship between ACEs and SUD development (Kranzler et al., <xref rid="r27" ref-type="bibr">2024</xref>). We extended these prior findings by identifying substance-specific patterns of association, whereby gene-by-environment interactions were more robust for AUD and CanUD than OUD. Interactions between genetics and ACEs in the same direction have also been previously seen for internalizing and externalizing symptomology (Wright &#x00026; Schwartz, <xref rid="r52" ref-type="bibr">2021</xref>).</p><p>The interactions between PGS and ACEs observed in this study highlight the importance of considering both genetic and environmental factors in the etiology of SUDs (Karcher et al., <xref rid="r21" ref-type="bibr">2019</xref>). Childhood adversity may shape key pathways that increase vulnerability to substance use problems, particularly through substance use initiation. For example, early-life adversity can impair emotional regulation (Miu et al., <xref rid="r36" ref-type="bibr">2022</xref>), disrupt stress-response systems (al&#x02019;Absi, Ginty, &#x00026; Lovallo, <xref rid="r3" ref-type="bibr">2021</xref>), and alter reward processing (Oltean, &#x00218;ofl&#x00103;u, Miu, &#x00026; Szent&#x000e1;gotai-T&#x00103;tar, <xref rid="r41" ref-type="bibr">2023</xref>), all of which affect substance use behaviors. Individuals exposed to childhood adversity may benefit from trauma-informed care that addresses emotional regulation skills and adaptive coping strategies, while those with high genetic liability may respond better to interventions targeting impulsivity or reward system dysregulation, biological systems implicated in genetic studies of SUDs (Deak &#x00026; Johnson, <xref rid="r8" ref-type="bibr">2021</xref>; Hatoum et al., <xref rid="r16" ref-type="bibr">2022</xref>). Although it has not yet been shown definitively for SUDs, those with greater genetic risk may also show a greater likelihood of response to pharmacological interventions, similar to what has been demonstrated for the effect of statins on cardiovascular risk (Damask et al., <xref rid="r6" ref-type="bibr">2020</xref>). In contrast, we speculate that the effects of ACEs may be more amenable to psychosocial treatments. Tailoring interventions to the specific pathways through which genetic and environmental influences manifest &#x02013; interpersonal difficulties, emotional dysregulation, or impaired functioning &#x02013; may improve treatment outcomes and reduce the likelihood of relapse in individuals with SUDs.</p><sec sec-type="other" id="sec15"><title>Limitations</title><p>This study has several limitations. First, the AFR GWAS used to calculate PGS were conducted in smaller samples than the EUR GWAS, which limited power to identify associations in AFR individuals across all three substances. To date, GWAS participants have predominantly comprised EUR individuals (86.55% in 2023), and there remains a clear need for participant representation to align more closely with population demographics (Mills &#x00026; Rahal, <xref rid="r35" ref-type="bibr">2020</xref>). Of the substances examined, the OUD GWAS sample size was smaller than both the AUD and CanUD samples. In addition, the prevalence of OUD in the Yale-Penn sample was lower than that of either AUD or CanUD. Thus, the power to detect associations with OUD was more limited than with AUD or CanUD, which may explain the less robust findings for OUD. Although higher ACEs factor scores reflect exposure to more extensive or varied forms of childhood trauma, we could not directly examine the severity of ACEs. Thus, this warrants further study using more refined measures of trauma exposure. Finally, the SSADDA relies on self-report (in the context of a semistructured interview conducted by trained interviewers), which may be subject to erroneous recall, particularly for past substance-related behaviors and early childhood experiences.</p></sec></sec><sec sec-type="conclusions" id="sec16"><title>Conclusions</title><p>This study highlights the associations of PGS and ACEs with substance use initiation and SUD severity, including gene-by-environment interactions that vary by substance and genetic ancestry. ACEs emerged as a consistent risk factor across all substances, underscoring their broad association with substance use behaviors. Although the associations of PGS were more limited, the AUD PGS was associated with AUD severity in both EUR and AFR individuals. Gene-by-environment interactions were consistent with early life adversity having a diminished impact on opioid use initiation and SUD severity as genetic liability increased. Collectively, these findings suggest a central role for ACEs in the pathogenesis of SUDs, potentially through their relationship to the onset of substance use and progression to problematic use.</p></sec><sec sec-type="supplementary-material" id="sec19"><title>Supporting information</title><supplementary-material id="sm01" position="float" content-type="local-data"><caption><title>SooHoo et al. supplementary material</title><p>SooHoo et al. supplementary material</p></caption><media xlink:href="S0033291725001163sup001.docx" id="d67e1287" position="anchor"/></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by the Mental Illness Research, Education and Clinical Center at the Crescenz VAMC and NIH grant AA030056.</p></ack><sec sec-type="supplementary-material" id="nts1"><title>Supplementary material</title><p>The supplementary material for this article can be found at <uri xlink:href="http://doi.org/10.1017/S0033291725001163">http://doi.org/10.1017/S0033291725001163</uri>.</p></sec><sec sec-type="funding-statement" id="sec17"><title>Funding statement</title><p>This work was supported by the University of Pennsylvania&#x02019;s Center for Undergraduate Research &#x00026; Fellowships College Alumni Research Grants (to JFS) and the Mental Illness Research, Education, and Clinical Center of the Crescenz VAMC (CND and HRK).</p></sec><sec sec-type="COI-statement" id="sec18"><title>Competing interests</title><p>Dr. Kranzler is a member of advisory boards for Altimmune and Clearmind Medicine; a consultant to Sobrera Pharmaceuticals and Altimmune; the recipient of research funding and medication supplies for an investigator-initiated study from Alkermes; a member of the American Society of Clinical Psychopharmacology&#x02019;s Alcohol Clinical Trials Initiative, which was supported in the last three years by Alkermes, Dicerna, Ethypharm, Imbrium, Indivior, Kinnov, Lilly, Otsuka, and Pear; and an inventor on U.S. provisional patent &#x0201c;Multi-ancestry Genome-wide Association Meta-analysis of Buprenorphine Treatment Response.&#x0201d; Dr. Gelernter receives grant funding from the US Department of Veterans Affairs and payment for editorial work for <italic toggle="yes">Complex Psychiatry.</italic>
</p></sec><ref-list id="refs1" content-type="normal"><title>References</title><ref id="r1"><mixed-citation publication-type="journal" id="ref1">
<string-name>
<surname>Agrawal</surname>, <given-names>A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Lynskey</surname>, <given-names>M. T</given-names>
</string-name>. (<year>2006</year>). <article-title>The genetic epidemiology of cannabis use, abuse and dependence</article-title>. <source>Addiction</source>, <volume>101</volume>(<issue>6</issue>), <fpage>801</fpage>&#x02013;<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1111/j.1360-0443.2006.01399.x</pub-id>
<pub-id pub-id-type="pmid">16696624</pub-id>
</mixed-citation></ref><ref id="r2"><mixed-citation publication-type="book" id="ref2">
<string-name>
<surname>Ahmad</surname>, <given-names>F. B.</given-names>
</string-name>, <string-name>
<surname>Cisewsk</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Rossen</surname>, <given-names>L. M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Sutton</surname>, <given-names>P</given-names>
</string-name>. (<year>2024</year>). <source>Provisional drug overdose death counts</source>. <publisher-loc>Hyattsville, MD</publisher-loc>: <publisher-name>National Center for Health Statistics</publisher-name>. <pub-id pub-id-type="doi">10.15620/cdc/20250305008</pub-id>
</mixed-citation></ref><ref id="r3"><mixed-citation publication-type="journal" id="ref3">
<string-name>
<surname>al&#x02019;Absi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Ginty</surname>, <given-names>A. T.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Lovallo</surname>, <given-names>W. R</given-names>
</string-name>. (<year>2021</year>). <article-title>Neurobiological mechanisms of early life adversity, blunted stress reactivity and risk for addiction</article-title>. <source>Neuropharmacology</source>, <volume>188</volume>, <fpage>108519</fpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2021.108519</pub-id>
<pub-id pub-id-type="pmid">33711348</pub-id>
</mixed-citation></ref><ref id="r4"><mixed-citation publication-type="book" id="ref4">
<collab>Center for Behavioral Health Statistics and Quality</collab>. (<year>2023</year>). <source>Results from the 2022 National survey on drug use and health: Detailed tables</source>. <publisher-loc>Rockville, MD</publisher-loc>: <publisher-name>Center for Behavioral Health Statistics and Quality</publisher-name>. <uri xlink:href="https://www.samhsa.gov/data/report/2022-nsduh-detailed-tables">https://www.samhsa.gov/data/report/2022-nsduh-detailed-tables</uri>
</mixed-citation></ref><ref id="r5"><mixed-citation publication-type="journal" id="ref5">
<string-name>
<surname>Cloitre</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Stolbach</surname>, <given-names>B. C.</given-names>
</string-name>, <string-name>
<surname>Herman</surname>, <given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>van der Kolk</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Pynoos</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Petkova</surname>, <given-names>E</given-names>
</string-name>. (<year>2009</year>). <article-title>A developmental approach to complex PTSD: Childhood and adult cumulative trauma as predictors of symptom complexity</article-title>. <source>Journal of Traumatic Stress</source>, <volume>22</volume>(<issue>5</issue>), <fpage>399</fpage>&#x02013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1002/jts.20444</pub-id>
<pub-id pub-id-type="pmid">19795402</pub-id>
</mixed-citation></ref><ref id="r6"><mixed-citation publication-type="journal" id="ref6">
<string-name>
<surname>Damask</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Steg</surname>, <given-names>P. G.</given-names>
</string-name>, <string-name>
<surname>Schwartz</surname>, <given-names>G. G.</given-names>
</string-name>, <string-name>
<surname>Szarek</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Hagstr&#x000f6;m</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Badimon</surname>, <given-names>L.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Paulding</surname>, <given-names>C</given-names>
</string-name>. (<year>2020</year>). <article-title>Patients with high genome-wide polygenic risk scores for coronary artery disease may receive greater clinical benefit from alirocumab treatment in the ODYSSEY OUTCOMES Trial</article-title>. <source>Circulation</source>, <volume>141</volume>(<issue>8</issue>), <fpage>624</fpage>&#x02013;<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1161/circulationaha.119.044434</pub-id>
<pub-id pub-id-type="pmid">31707832</pub-id>
</mixed-citation></ref><ref id="r7"><mixed-citation publication-type="journal" id="ref7">
<string-name>
<surname>Das</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Forer</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Sch&#x000f6;nherr</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Sidore</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Locke</surname>, <given-names>A. E.</given-names>
</string-name>, <string-name>
<surname>Kwong</surname>, <given-names>A.</given-names>
</string-name>, &#x02026; <string-name>
<surname>Fuchsberger</surname>, <given-names>C</given-names>
</string-name>. (<year>2016</year>). <article-title>Next-generation genotype imputation service and methods</article-title>. <source>Nature Genetics</source>, <volume>48</volume>(<issue>10</issue>), <fpage>1284</fpage>&#x02013;<lpage>1287</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3656</pub-id>
<pub-id pub-id-type="pmid">27571263</pub-id>
</mixed-citation></ref><ref id="r8"><mixed-citation publication-type="journal" id="ref8">
<string-name>
<surname>Deak</surname>, <given-names>J. D.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Johnson</surname>, <given-names>E. C</given-names>
</string-name>. (<year>2021</year>). <article-title>Genetics of substance use disorders: A review</article-title>. <source>Psychological Medicine</source>, <volume>51</volume>(<issue>13</issue>), <fpage>2189</fpage>&#x02013;<lpage>2200</lpage>. <pub-id pub-id-type="doi">10.1017/s0033291721000969</pub-id>
<pub-id pub-id-type="pmid">33879270</pub-id>
</mixed-citation></ref><ref id="r9"><mixed-citation publication-type="journal" id="ref9">
<string-name>
<surname>Deol</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Siddiqui</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Paracha</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Mujovic</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Abro</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Chang</surname>, <given-names>S. R.</given-names>
</string-name>, <string-name>
<surname>Abid</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Tyler</surname>, <given-names>J. H.</given-names>
</string-name>, <string-name>
<surname>Rehman</surname>, <given-names>H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Bera</surname>, <given-names>S</given-names>
</string-name>. (<year>2023</year>). <article-title>Exploring the link between ACEs and opioid use: A systematic review</article-title>. <source>Journal of Opioid Management</source>, <volume>19</volume>(<issue>4</issue>), <fpage>343</fpage>&#x02013;<lpage>364</lpage>.<pub-id pub-id-type="pmid">37644792</pub-id>
</mixed-citation></ref><ref id="r10"><mixed-citation publication-type="journal" id="ref10">
<string-name>
<surname>Dube</surname>, <given-names>S. R.</given-names>
</string-name>, <string-name>
<surname>Miller</surname>, <given-names>J. W.</given-names>
</string-name>, <string-name>
<surname>Brown</surname>, <given-names>D. W.</given-names>
</string-name>, <string-name>
<surname>Giles</surname>, <given-names>W. H.</given-names>
</string-name>, <string-name>
<surname>Felitti</surname>, <given-names>V. J.</given-names>
</string-name>, <string-name>
<surname>Dong</surname>, <given-names>M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Anda</surname>, <given-names>R. F</given-names>
</string-name>. (<year>2006</year>). <article-title>Adverse childhood experiences and the association with ever using alcohol and initiating alcohol use during adolescence</article-title>. <source>Journal of Adolescent Health</source>, <volume>38</volume>(<issue>4</issue>), <fpage>444.e1</fpage>&#x02013;<lpage>444.e10</lpage>. <pub-id pub-id-type="doi">10.1016/j.jadohealth.2005.06.006</pub-id>
</mixed-citation></ref><ref id="r11"><mixed-citation publication-type="journal" id="ref11">
<string-name>
<surname>Evans</surname>, <given-names>E. A.</given-names>
</string-name>, <string-name>
<surname>Goff</surname>, <given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Upchurch</surname>, <given-names>D. M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Grella</surname>, <given-names>C. E</given-names>
</string-name>. (<year>2020</year>). <article-title>Childhood adversity and mental health comorbidity in men and women with opioid use disorders</article-title>. <source>Addictive Behaviors</source>, <volume>102</volume>, <fpage>106149</fpage>. <pub-id pub-id-type="doi">10.1016/j.addbeh.2019.106149</pub-id>
<pub-id pub-id-type="pmid">31855783</pub-id>
</mixed-citation></ref><ref id="r12"><mixed-citation publication-type="journal" id="ref12">
<string-name>
<surname>Garland</surname>, <given-names>E. L.</given-names>
</string-name>, <string-name>
<surname>Reese</surname>, <given-names>S. E.</given-names>
</string-name>, <string-name>
<surname>Bedford</surname>, <given-names>C. E.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Baker</surname>, <given-names>A. K</given-names>
</string-name>. (<year>2019</year>). <article-title>Adverse childhood experiences predict autonomic indices of emotion dysregulation and negative emotional cue-elicited craving among female opioid-treated chronic pain patients</article-title>. <source>Development and Psychopathology</source>, <volume>31</volume>(<issue>3</issue>), <fpage>1101</fpage>&#x02013;<lpage>1110</lpage>. <pub-id pub-id-type="doi">10.1017/S0954579419000622</pub-id>
<pub-id pub-id-type="pmid">31060644</pub-id>
</mixed-citation></ref><ref id="r54"><mixed-citation publication-type="journal" id="ref54">
<string-name>
<surname>Ge</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>C. Y.</given-names>
</string-name>, <string-name>
<surname>Ni</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Feng</surname>, <given-names>Y. A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Smoller</surname>, <given-names>J. W.</given-names>
</string-name> (<year>2019</year>). <article-title>Polygenic prediction via Bayesian regression and continuous shrinkage priors</article-title>. <source>Nat Commun</source>, <volume>10</volume>(<issue>1</issue>), <fpage>1776</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-09718-5</pub-id>.<pub-id pub-id-type="pmid">30992449</pub-id>
</mixed-citation></ref><ref id="r13"><mixed-citation publication-type="journal" id="ref13">
<string-name>
<surname>Gelernter</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Sherva</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Koesterer</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Almasy</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Kranzler</surname>, <given-names>H. R.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Farrer</surname>, <given-names>L</given-names>
</string-name>. (<year>2014</year>). <article-title>Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene</article-title>. <source>Molecular Psychiatry</source>, <volume>19</volume>(<issue>6</issue>), <fpage>717</fpage>&#x02013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.99</pub-id>
<pub-id pub-id-type="pmid">23958962</pub-id>
</mixed-citation></ref><ref id="r14"><mixed-citation publication-type="journal" id="ref14">
<string-name>
<surname>Gerhardt</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Berhe</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Moessnang</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Horning</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Kiefer</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Tost</surname>, <given-names>H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Vollst&#x000e4;dt-Klein</surname>, <given-names>S</given-names>
</string-name>. (<year>2023</year>). <article-title>Lack of amygdala habituation to negative emotional faces in alcohol use disorder and the relation to adverse childhood experiences</article-title>. <source>Addiction Biology</source>, <volume>28</volume>(<issue>1</issue>), <fpage>e13251</fpage>. <pub-id pub-id-type="doi">10.1111/adb.13251</pub-id>
<pub-id pub-id-type="pmid">36577733</pub-id>
</mixed-citation></ref><ref id="r15"><mixed-citation publication-type="journal" id="ref15">
<string-name>
<surname>Gillespie</surname>, <given-names>N. A.</given-names>
</string-name>, <string-name>
<surname>Neale</surname>, <given-names>M. C.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Kendler</surname>, <given-names>K. S</given-names>
</string-name>. (<year>2009</year>). <article-title>Pathways to cannabis abuse: A multi-stage model from cannabis availability, cannabis initiation and progression to abuse</article-title>. <source>Addiction</source>, <volume>104</volume>(<issue>3</issue>), <fpage>430</fpage>&#x02013;<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1111/j.1360-0443.2008.02456.x</pub-id>
<pub-id pub-id-type="pmid">19207351</pub-id>
</mixed-citation></ref><ref id="r16"><mixed-citation publication-type="journal" id="ref16">
<string-name>
<surname>Hatoum</surname>, <given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>, <given-names>E. C.</given-names>
</string-name>, <string-name>
<surname>Colbert</surname>, <given-names>S. M. C.</given-names>
</string-name>, <string-name>
<surname>Polimanti</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Walters</surname>, <given-names>R. K.</given-names>
</string-name>, <string-name>
<surname>Gelernter</surname>, <given-names>J.</given-names>
</string-name>, &#x02026;<string-name>
<surname>Agrawal</surname>, <given-names>A</given-names>
</string-name>. (<year>2022</year>). <article-title>The addiction risk factor: A unitary genetic vulnerability characterizes substance use disorders and their associations with common correlates</article-title>. <source>Neuropsychopharmacology</source>, <volume>47</volume>(<issue>10</issue>), <fpage>1739</fpage>&#x02013;<lpage>1745</lpage>. <pub-id pub-id-type="doi">10.1038/s41386-021-01209-w</pub-id>
<pub-id pub-id-type="pmid">34750568</pub-id>
</mixed-citation></ref><ref id="r17"><mixed-citation publication-type="journal" id="ref17">
<string-name>
<surname>Hines</surname>, <given-names>L. A.</given-names>
</string-name>, <string-name>
<surname>Jones</surname>, <given-names>H. J.</given-names>
</string-name>, <string-name>
<surname>Hickman</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Lynskey</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Howe</surname>, <given-names>L. D.</given-names>
</string-name>, <string-name>
<surname>Zammit</surname>, <given-names>S.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Heron</surname>, <given-names>J</given-names>
</string-name>. (<year>2023</year>). <article-title>Adverse childhood experiences and adolescent cannabis use trajectories: Findings from a longitudinal UK birth cohort</article-title>. <source>Lancet Public Health</source>, <volume>8</volume>(<issue>6</issue>), <fpage>e442</fpage>&#x02013;<lpage>e452</lpage>. <pub-id pub-id-type="doi">10.1016/s2468-2667(23)00095-6</pub-id>
<pub-id pub-id-type="pmid">37244674</pub-id>
</mixed-citation></ref><ref id="r18"><mixed-citation publication-type="journal" id="ref18">
<string-name>
<surname>Holt</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Buckley</surname>, <given-names>H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Whelan</surname>, <given-names>S.</given-names>
</string-name> (<year>2008</year>). <article-title>The impact of exposure to domestic violence on children and young people: A review of the literature</article-title>. <source>Child Abuse &#x00026; Neglect</source>, <volume>32</volume>(<issue>8</issue>), <fpage>797</fpage>&#x02013;<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1016/j.chiabu.2008.02.004</pub-id>
<pub-id pub-id-type="pmid">18752848</pub-id>
</mixed-citation></ref><ref id="r19"><mixed-citation publication-type="journal" id="ref19">
<string-name>
<surname>Jaffee</surname>, <given-names>S. R.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Price</surname>, <given-names>T. S</given-names>
</string-name>. (<year>2007</year>). <article-title>Gene-environment correlations: A review of the evidence and implications for prevention of mental illness</article-title>. <source>Molecular Psychiatry</source>, <volume>12</volume>(<issue>5</issue>), <fpage>432</fpage>&#x02013;<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001950</pub-id>
<pub-id pub-id-type="pmid">17453060</pub-id>
</mixed-citation></ref><ref id="r20"><mixed-citation publication-type="journal" id="ref20">
<string-name>
<surname>Johnson</surname>, <given-names>E. C.</given-names>
</string-name>, <string-name>
<surname>Demontis</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Thorgeirsson</surname>, <given-names>T. E.</given-names>
</string-name>, <string-name>
<surname>Walters</surname>, <given-names>R. K.</given-names>
</string-name>, <string-name>
<surname>Polimanti</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Hatoum</surname>, <given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>Sanchez-Roige</surname>, <given-names>S.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Agrawal</surname>, <given-names>A</given-names>
</string-name>. (<year>2020</year>). <article-title>A large-scale genome-wide association study meta-analysis of cannabis use disorder</article-title>. <source>Lancet Psychiatry</source>, <volume>7</volume>(<issue>12</issue>), <fpage>1032</fpage>&#x02013;<lpage>1045</lpage>. <pub-id pub-id-type="doi">10.1016/s2215-0366(20)30339-4</pub-id>
<pub-id pub-id-type="pmid">33096046</pub-id>
</mixed-citation></ref><ref id="r21"><mixed-citation publication-type="journal" id="ref21">
<string-name>
<surname>Karcher</surname>, <given-names>N. R.</given-names>
</string-name>, <string-name>
<surname>Barch</surname>, <given-names>D. M.</given-names>
</string-name>, <string-name>
<surname>Demers</surname>, <given-names>C. H.</given-names>
</string-name>, <string-name>
<surname>Baranger</surname>, <given-names>D. A. A.</given-names>
</string-name>, <string-name>
<surname>Heath</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<surname>Lynskey</surname>, <given-names>M. T.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Agrawal</surname>, <given-names>A</given-names>
</string-name>. (<year>2019</year>). <article-title>Genetic predisposition vs individual-specific processes in the association between psychotic-like experiences and cannabis use</article-title>. <source>JAMA Psychiatry</source>, <volume>76</volume>(<issue>1</issue>), <fpage>87</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2018.2546</pub-id>
<pub-id pub-id-type="pmid">30347017</pub-id>
</mixed-citation></ref><ref id="r22"><mixed-citation publication-type="journal" id="ref22">
<string-name>
<surname>Kember</surname>, <given-names>R. L.</given-names>
</string-name>, <string-name>
<surname>Hartwell</surname>, <given-names>E. E.</given-names>
</string-name>, <string-name>
<surname>Xu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Rotenberg</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Almasy</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>, <given-names>H.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Kranzler</surname>, <given-names>H. R</given-names>
</string-name>. (<year>2023</year>). <article-title>Phenome-wide association analysis of substance use disorders in a deeply phenotyped sample</article-title>. <source>Biological Psychiatry</source>, <volume>93</volume>(<issue>6</issue>), <fpage>536</fpage>&#x02013;<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2022.08.010</pub-id>
<pub-id pub-id-type="pmid">36273948</pub-id>
</mixed-citation></ref><ref id="r23"><mixed-citation publication-type="journal" id="ref23">
<string-name>
<surname>Kember</surname>, <given-names>R. L.</given-names>
</string-name>, <string-name>
<surname>Vickers-Smith</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Xu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Toikumo</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Niarchou</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>, <given-names>H.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Million Veteran</surname>, <given-names>P</given-names>
</string-name>. (<year>2022</year>). <article-title>Cross-ancestry meta-analysis of opioid use disorder uncovers novel loci with predominant effects in brain regions associated with addiction</article-title>. <source>Nature Neuroscience</source>, <volume>25</volume>(<issue>10</issue>), <fpage>1279</fpage>&#x02013;<lpage>1287</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-022-01160-z</pub-id>
<pub-id pub-id-type="pmid">36171425</pub-id>
</mixed-citation></ref><ref id="r24"><mixed-citation publication-type="journal" id="ref24">
<string-name>
<surname>Kendler</surname>, <given-names>K. S.</given-names>
</string-name>, <string-name>
<surname>Karkowski</surname>, <given-names>L. M.</given-names>
</string-name>, <string-name>
<surname>Neale</surname>, <given-names>M. C.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Prescott</surname>, <given-names>C. A</given-names>
</string-name>. (<year>2000</year>). <article-title>Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins</article-title>. <source>Archives of General Psychiatry</source>, <volume>57</volume>(<issue>3</issue>), <fpage>261</fpage>&#x02013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.57.3.261</pub-id>
<pub-id pub-id-type="pmid">10711912</pub-id>
</mixed-citation></ref><ref id="r25"><mixed-citation publication-type="journal" id="ref25">
<string-name>
<surname>Khoury</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Tang</surname>, <given-names>Y. L.</given-names>
</string-name>, <string-name>
<surname>Bradley</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Cubells</surname>, <given-names>J. F.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Ressler</surname>, <given-names>K. J</given-names>
</string-name>. (<year>2010</year>). <article-title>Substance use, childhood traumatic experience, and posttraumatic stress disorder in an urban civilian population</article-title>. <source>Depression and Anxiety</source>, <volume>27</volume>(<issue>12</issue>), <fpage>1077</fpage>&#x02013;<lpage>1086</lpage>. <pub-id pub-id-type="doi">10.1002/da.20751</pub-id>
<pub-id pub-id-type="pmid">21049532</pub-id>
</mixed-citation></ref><ref id="r26"><mixed-citation publication-type="journal" id="ref26">
<string-name>
<surname>Koopmans</surname>, <given-names>J. R.</given-names>
</string-name>, <string-name>
<surname>Slutske</surname>, <given-names>W. S.</given-names>
</string-name>, <string-name>
<surname>van Baal</surname>, <given-names>G. C. M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Boomsma</surname>, <given-names>D. I</given-names>
</string-name>. (<year>1999</year>). <article-title>The influence of religion on alcohol use initiation: Evidence for genotype x environment interaction</article-title>. <source>Behavior Genetics</source>, <volume>29</volume>(<issue>6</issue>), <fpage>445</fpage>&#x02013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1023/A:1021679005623</pub-id>
<pub-id pub-id-type="pmid">10857249</pub-id>
</mixed-citation></ref><ref id="r27"><mixed-citation publication-type="journal" id="ref27">
<string-name>
<surname>Kranzler</surname>, <given-names>H. R.</given-names>
</string-name>, <string-name>
<surname>Davis</surname>, <given-names>C. N.</given-names>
</string-name>, <string-name>
<surname>Feinn</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Jinwala</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Khan</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Oikonomou</surname>, <given-names>A.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Kember</surname>, <given-names>R. L</given-names>
</string-name>. (<year>2024</year>). <article-title>Gene &#x000d7; environment effects and mediation involving adverse childhood events, mood and anxiety disorders, and substance dependence</article-title>. <source>Nature Human Behaviour</source>, <volume>8</volume>(<issue>8</issue>), <fpage>1616</fpage>&#x02013;<lpage>1627</lpage>. <pub-id pub-id-type="doi">10.1038/s41562-024-01885-w</pub-id>
</mixed-citation></ref><ref id="r28"><mixed-citation publication-type="journal" id="ref28">
<string-name>
<surname>Leonard</surname>, <given-names>K. E.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Eiden</surname>, <given-names>R. D</given-names>
</string-name>. (<year>2007</year>). <article-title>Marital and family processes in the context of alcohol use and alcohol disorders</article-title>. <source>Annual Review of Clinical Psychology</source>, <volume>3</volume>, <fpage>285</fpage>&#x02013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.clinpsy.3.022806.091424</pub-id>
</mixed-citation></ref><ref id="r29"><mixed-citation publication-type="journal" id="ref29">
<string-name>
<surname>Levey</surname>, <given-names>D. F.</given-names>
</string-name>, <string-name>
<surname>Galimberti</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Deak</surname>, <given-names>J. D.</given-names>
</string-name>, <string-name>
<surname>Wendt</surname>, <given-names>F. R.</given-names>
</string-name>, <string-name>
<surname>Bhattacharya</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Koller</surname>, <given-names>D.</given-names>
</string-name>, &#x02026; <collab>Veterans Affairs Million Veteran Program</collab>. (<year>2023</year>). <article-title>Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications</article-title>. <source>Nature Genetics</source>, <volume>55</volume>(<issue>12</issue>), <fpage>2094</fpage>&#x02013;<lpage>2103</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-023-01563-z</pub-id>
<pub-id pub-id-type="pmid">37985822</pub-id>
</mixed-citation></ref><ref id="r30"><mixed-citation publication-type="journal" id="ref30">
<string-name>
<surname>Leza</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Siria</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>L&#x000f3;pez-Go&#x000f1;i</surname>, <given-names>J. J.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Fern&#x000e1;ndez-Montalvo</surname>, <given-names>J.</given-names>
</string-name> (<year>2021</year>). <article-title>Adverse childhood experiences (ACEs) and substance use disorder (SUD): A scoping review</article-title>. <source>Drug and Alcohol Dependence</source>, <volume>221</volume>, <fpage>108563</fpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2021.108563</pub-id>
<pub-id pub-id-type="pmid">33561668</pub-id>
</mixed-citation></ref><ref id="r31"><mixed-citation publication-type="journal" id="ref31">
<string-name>
<surname>Madigan</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Thiemann</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Deneault</surname>, <given-names>A.-A.</given-names>
</string-name>, <string-name>
<surname>Fearon</surname>, <given-names>R. M. P.</given-names>
</string-name>, <string-name>
<surname>Racine</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Park</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Lunney</surname>, <given-names>C. A.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Neville</surname>, <given-names>R. D</given-names>
</string-name>. (<year>2025</year>). <article-title>Prevalence of adverse childhood experiences in child population samples: A systematic review and meta-analysis</article-title>. <source>JAMA Pediatrics</source>, <volume>179</volume>(<issue>1</issue>), <fpage>19</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1001/jamapediatrics.2024.4385</pub-id>
<pub-id pub-id-type="pmid">39527072</pub-id>
</mixed-citation></ref><ref id="r32"><mixed-citation publication-type="journal" id="ref32">
<string-name>
<surname>Meadows</surname>, <given-names>A. L.</given-names>
</string-name>, <string-name>
<surname>Strickland</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Hyder</surname>, <given-names>S. M.</given-names>
</string-name>, <string-name>
<surname>Basconi</surname>, <given-names>R. C.</given-names>
</string-name>, <string-name>
<surname>Stull</surname>, <given-names>M. E.</given-names>
</string-name>, <string-name>
<surname>Wagner</surname>, <given-names>F. P.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Rush</surname>, <given-names>C. R</given-names>
</string-name>. (<year>2023</year>). <article-title>Adverse childhood experiences and early initiation of substance use: A survival analysis</article-title>. <source>The International Journal of Psychiatry in Medicine</source>, <volume>59</volume>(<issue>2</issue>), <fpage>218</fpage>&#x02013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1177/00912174231195751</pub-id>
<pub-id pub-id-type="pmid">37594029</pub-id>
</mixed-citation></ref><ref id="r33"><mixed-citation publication-type="journal" id="ref33">
<string-name>
<surname>Meyers</surname>, <given-names>J. L.</given-names>
</string-name>, <string-name>
<surname>Shmulewitz</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Wall</surname>, <given-names>M. M.</given-names>
</string-name>, <string-name>
<surname>Keyes</surname>, <given-names>K. M.</given-names>
</string-name>, <string-name>
<surname>Aharonovich</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Spivak</surname>, <given-names>B.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Hasin</surname>, <given-names>D</given-names>
</string-name>. (<year>2015</year>). <article-title>Childhood adversity moderates the effect of ADH1B on risk for alcohol-related phenotypes in Jewish Israeli drinkers</article-title>. <source>Addiction Biology</source>, <volume>20</volume>(<issue>1</issue>), <fpage>205</fpage>&#x02013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1111/adb.12102</pub-id>
<pub-id pub-id-type="pmid">24164917</pub-id>
</mixed-citation></ref><ref id="r34"><mixed-citation publication-type="journal" id="ref34">
<string-name>
<surname>Milaniak</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Watson</surname>, <given-names>B.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Jaffee</surname>, <given-names>S. R.</given-names>
</string-name> (<year>2015</year>). <article-title>Gene-environment interplay and substance use: A review of recent findings</article-title>. <source>Current Addiction Reports</source>, <volume>2</volume>(<issue>4</issue>), <fpage>364</fpage>&#x02013;<lpage>371</lpage>. <pub-id pub-id-type="doi">10.1007/s40429-015-0069-4</pub-id>
</mixed-citation></ref><ref id="r35"><mixed-citation publication-type="journal" id="ref35">
<string-name>
<surname>Mills</surname>, <given-names>M. C.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Rahal</surname>, <given-names>C</given-names>
</string-name>. (<year>2020</year>). <article-title>The GWAS diversity monitor tracks diversity by disease in real time</article-title>. <source>Nature Genetics</source>, <volume>52</volume>(<issue>3</issue>), <fpage>242</fpage>&#x02013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1038/s41588-020-0580-y</pub-id>
<pub-id pub-id-type="pmid">32139905</pub-id>
</mixed-citation></ref><ref id="r36"><mixed-citation publication-type="journal" id="ref36">
<string-name>
<surname>Miu</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<surname>Szent&#x000e1;gotai-T&#x00103;tar</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Bal&#x000e1;zsi</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Nechita</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Bunea</surname>, <given-names>I.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Pollak</surname>, <given-names>S. D</given-names>
</string-name>. (<year>2022</year>). <article-title>Emotion regulation as mediator between childhood adversity and psychopathology: A meta-analysis</article-title>. <source>Clinical Psychology Review</source>, <volume>93</volume>, <fpage>102141</fpage>. <pub-id pub-id-type="doi">10.1016/j.cpr.2022.102141</pub-id>
<pub-id pub-id-type="pmid">35219929</pub-id>
</mixed-citation></ref><ref id="r37"><mixed-citation publication-type="journal" id="ref37">
<string-name>
<surname>M&#x000fc;ller</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Vandeleur</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Rodgers</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>R&#x000f6;ssler</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Castelao</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Preisig</surname>, <given-names>M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Ajdacic-Gross</surname>, <given-names>V</given-names>
</string-name>. (<year>2015</year>). <article-title>Childhood adversities as specific contributors to the co-occurrence of posttraumatic stress and alcohol use disorders</article-title>. <source>Psychiatry Research</source>, <volume>228</volume>(<issue>3</issue>), <fpage>251</fpage>&#x02013;<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2015.06.034</pub-id>
<pub-id pub-id-type="pmid">26163721</pub-id>
</mixed-citation></ref><ref id="r38"><mixed-citation publication-type="book" id="ref38">
<string-name>
<surname>Muth&#x000e9;n</surname>, <given-names>L. K.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Muth&#x000e9;n</surname>, <given-names>B. O.</given-names>
</string-name> (<year>1998&#x02013;2017</year>). <source>Mplus user&#x02019;s guide</source> (8th ed.). <publisher-loc>Los Angeles, CA</publisher-loc>: <publisher-name>Muth&#x000e9;n &#x00026; Muth&#x000e9;n</publisher-name>.</mixed-citation></ref><ref id="r39"><mixed-citation publication-type="journal" id="ref39">
<string-name>
<surname>Na</surname>, <given-names>P. J.</given-names>
</string-name>, <string-name>
<surname>Deak</surname>, <given-names>J. D.</given-names>
</string-name>, <string-name>
<surname>Kranzler</surname>, <given-names>H. R.</given-names>
</string-name>, <string-name>
<surname>Pietrzak</surname>, <given-names>R. H.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Gelernter</surname>, <given-names>J</given-names>
</string-name>. (<year>2024</year>). <article-title>Genetic and non-genetic predictors of risk for opioid dependence</article-title>. <source>Psychological Medicine</source>, <volume>54</volume>(<issue>8</issue>), <fpage>1779</fpage>&#x02013;<lpage>1786</lpage>. <pub-id pub-id-type="doi">10.1017/s0033291723003732</pub-id>
<pub-id pub-id-type="pmid">38317430</pub-id>
</mixed-citation></ref><ref id="r40"><mixed-citation publication-type="book" id="ref40">
<collab>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</collab>. (<year>2024</year>). <source>Alcohol-Related Emergencies and Deaths in the United States.</source>
<publisher-loc>Bethesda, MD</publisher-loc>: <publisher-name>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</publisher-name>. <uri xlink:href="https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-topics/alcohol-facts-and-statistics/alcohol-related-emergencies-and-deaths-united-states">https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-topics/alcohol-facts-and-statistics/alcohol-related-emergencies-and-deaths-united-states</uri>
</mixed-citation></ref><ref id="r41"><mixed-citation publication-type="journal" id="ref41">
<string-name>
<surname>Oltean</surname>, <given-names>L. E.</given-names>
</string-name>, <string-name>
<surname>&#x00218;ofl&#x00103;u</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Miu</surname>, <given-names>A. C.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Szent&#x000e1;gotai-T&#x00103;tar</surname>, <given-names>A</given-names>
</string-name>. (<year>2023</year>). <article-title>Childhood adversity and impaired reward processing: A meta-analysis</article-title>. <source>Child Abuse &#x00026; Neglect</source>, <volume>142</volume>(<issue>Pt 1</issue>), <fpage>105596</fpage>. <pub-id pub-id-type="doi">10.1016/j.chiabu.2022.105596</pub-id>
<pub-id pub-id-type="pmid">35346502</pub-id>
</mixed-citation></ref><ref id="r42"><mixed-citation publication-type="journal" id="ref42">
<string-name>
<surname>Pasman</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Verweij</surname>, <given-names>K. J. H.</given-names>
</string-name>, <string-name>
<surname>Gerring</surname>, <given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Stringer</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Sanchez-Roige</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Treur</surname>, <given-names>J. L.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Vink</surname>, <given-names>J. M</given-names>
</string-name>. (<year>2018</year>). <article-title>GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia</article-title>. <source>Nature Neuroscience</source>, <volume>21</volume>(<issue>9</issue>), <fpage>1161</fpage>&#x02013;<lpage>1170</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0206-1</pub-id>
<pub-id pub-id-type="pmid">30150663</pub-id>
</mixed-citation></ref><ref id="r43"><mixed-citation publication-type="journal" id="ref43">
<string-name>
<surname>Pierucci-Lagha</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Gelernter</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Chan</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Arias</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Cubells</surname>, <given-names>J. F.</given-names>
</string-name>, <string-name>
<surname>Farrer</surname>, <given-names>L.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Kranzler</surname>, <given-names>H. R</given-names>
</string-name>. (<year>2007</year>). <article-title>Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA)</article-title>. <source>Drug and Alcohol Dependence</source>, <volume>91</volume>(<issue>1</issue>), <fpage>85</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2007.04.014</pub-id>
<pub-id pub-id-type="pmid">17590536</pub-id>
</mixed-citation></ref><ref id="r44"><mixed-citation publication-type="journal" id="ref44">
<string-name>
<surname>Quach</surname>, <given-names>B. C.</given-names>
</string-name>, <string-name>
<surname>Bray</surname>, <given-names>M. J.</given-names>
</string-name>, <string-name>
<surname>Gaddis</surname>, <given-names>N. C.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Palviainen</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Minica</surname>, <given-names>C. C.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Hancock</surname>, <given-names>D. B</given-names>
</string-name>. (<year>2020</year>). <article-title>Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits</article-title>. <source>Nature Communications</source>, <volume>11</volume>(<issue>1</issue>), <fpage>5562</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-19265-z</pub-id>
</mixed-citation></ref><ref id="r45"><mixed-citation publication-type="journal" id="ref45">
<string-name>
<surname>Rambau</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Forstner</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Wegener</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>M&#x000fc;cke</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Wissussek</surname>, <given-names>C. T. S.</given-names>
</string-name>, <string-name>
<surname>Staufenbiel</surname>, <given-names>S. M.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Conrad</surname>, <given-names>R</given-names>
</string-name>. (<year>2018</year>). <article-title>Childhood adversities, bonding, and personality in social anxiety disorder with alcohol use disorder</article-title>. <source>Psychiatry Research</source>, <volume>262</volume>, <fpage>295</fpage>&#x02013;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2018.02.006</pub-id>
<pub-id pub-id-type="pmid">29477673</pub-id>
</mixed-citation></ref><ref id="r46"><mixed-citation publication-type="journal" id="ref46">
<string-name>
<surname>Sanchez-Roige</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Palmer</surname>, <given-names>A. A.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Clarke</surname>, <given-names>T. K</given-names>
</string-name>. (<year>2020</year>). <article-title>Recent efforts to dissect the genetic basis of alcohol use and abuse</article-title>. <source>Biological Psychiatry</source>, <volume>87</volume>(<issue>7</issue>), <fpage>609</fpage>&#x02013;<lpage>618</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2019.09.011</pub-id>
<pub-id pub-id-type="pmid">31733789</pub-id>
</mixed-citation></ref><ref id="r47"><mixed-citation publication-type="journal" id="ref47">
<string-name>
<surname>Schwartz</surname>, <given-names>J. A.</given-names>
</string-name>, <string-name>
<surname>Wright</surname>, <given-names>E. M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Valgardson</surname>, <given-names>B. A</given-names>
</string-name>. (<year>2019</year>). <article-title>Adverse childhood experiences and deleterious outcomes in adulthood: A consideration of the simultaneous role of genetic and environmental influences in two independent samples from the United States</article-title>. <source>Child Abuse &#x00026; Neglect</source>, <volume>88</volume>, <fpage>420</fpage>&#x02013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1016/j.chiabu.2018.12.022</pub-id>
<pub-id pub-id-type="pmid">30605796</pub-id>
</mixed-citation></ref><ref id="r48"><mixed-citation publication-type="journal" id="ref48">
<string-name>
<surname>Sreenivasulu</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Prathyusha</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Ezhumalai</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Narayanan</surname>, <given-names>G.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Murthy</surname>, <given-names>P</given-names>
</string-name>. (<year>2024</year>). <article-title>Adverse childhood experiences, coping and resilience in persons with alcohol use disorder and their non-drinking siblings in high-density families: A case-control study</article-title>. <source>Indian Journal of Psychological Medicine</source>, <volume>46</volume>(<issue>2</issue>), <fpage>139</fpage>&#x02013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1177/02537176231219769</pub-id>
<pub-id pub-id-type="pmid">38725730</pub-id>
</mixed-citation></ref><ref id="r49"><mixed-citation publication-type="journal" id="ref49">
<string-name>
<surname>Tang</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Ports</surname>, <given-names>K. A.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>, <given-names>K.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Lin</surname>, <given-names>H. C</given-names>
</string-name>. (<year>2020</year>). <article-title>Adverse childhood experiences, internalizing/externalizing symptoms, and associated prescription opioid misuse: A mediation analysis</article-title>. <source>Preventive Medicine</source>, <volume>134</volume>, <fpage>106034</fpage>. <pub-id pub-id-type="doi">10.1016/j.ypmed.2020.106034</pub-id>
<pub-id pub-id-type="pmid">32087177</pub-id>
</mixed-citation></ref><ref id="r50"><mixed-citation publication-type="journal" id="ref50">
<string-name>
<surname>Tasmim</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Le Foll</surname>, <given-names>B.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Hassan</surname>, <given-names>A. N</given-names>
</string-name>. (<year>2022</year>). <article-title>Moderators for the relationship between post-traumatic stress disorder and opioid use disorder</article-title>. <source>Journal of Dual Diagnosis</source>, <volume>18</volume>(<issue>1</issue>), <fpage>3</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1080/15504263.2021.2016341</pub-id>
<pub-id pub-id-type="pmid">34982654</pub-id>
</mixed-citation></ref><ref id="r51"><mixed-citation publication-type="journal" id="ref51">
<string-name>
<surname>Verweij</surname>, <given-names>K. J. H.</given-names>
</string-name>, <string-name>
<surname>Zietsch</surname>, <given-names>B. P.</given-names>
</string-name>, <string-name>
<surname>Lynskey</surname>, <given-names>M. T.</given-names>
</string-name>, <string-name>
<surname>Medland</surname>, <given-names>S. E.</given-names>
</string-name>, <string-name>
<surname>Neale</surname>, <given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Martin</surname>, <given-names>N. G.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Vink</surname>, <given-names>J. M</given-names>
</string-name>. (<year>2010</year>). <article-title>Genetic and environmental influences on cannabis use initiation and problematic use: A meta-analysis of twin studies</article-title>. <source>Addiction</source>, <volume>105</volume>(<issue>3</issue>), <fpage>417</fpage>&#x02013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1111/j.1360-0443.2009.02831.x</pub-id>
<pub-id pub-id-type="pmid">20402985</pub-id>
</mixed-citation></ref><ref id="r52"><mixed-citation publication-type="journal" id="ref52">
<string-name>
<surname>Wright</surname>, <given-names>E. M.</given-names>
</string-name>, &#x00026; <string-name>
<surname>Schwartz</surname>, <given-names>J. A</given-names>
</string-name>. (<year>2021</year>). <article-title>The influence of adverse childhood experiences on internalizing and externalizing problems in early adulthood: Evidence of a gene &#x000d7; environment &#x000d7; sex interaction</article-title>. <source>Child Abuse &#x00026; Neglect</source>, <volume>114</volume>, <fpage>104962</fpage>. <pub-id pub-id-type="doi">10.1016/j.chiabu.2021.104962</pub-id>
<pub-id pub-id-type="pmid">33548690</pub-id>
</mixed-citation></ref><ref id="r53"><mixed-citation publication-type="journal" id="ref53">
<string-name>
<surname>Zhou</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Kember</surname>, <given-names>R. L.</given-names>
</string-name>, <string-name>
<surname>Deak</surname>, <given-names>J. D.</given-names>
</string-name>, <string-name>
<surname>Xu</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Toikumo</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>, <given-names>K.</given-names>
</string-name>,&#x02026;<string-name>
<surname>Million Veteran</surname>, <given-names>P</given-names>
</string-name>. (<year>2023</year>). <article-title>Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals</article-title>. <source>Nature Medicine</source>, <volume>29</volume>(<issue>12</issue>), <fpage>3184</fpage>&#x02013;<lpage>3192</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-023-02653-5</pub-id>
</mixed-citation></ref></ref-list></back></article>